Pharmacological inhibition of poly(ADP-ribose) polymerase in cardiovascular disorders: Future directions

Current Vascular Pharmacology

Volumn 3, Issue 3, 2005, Pages 301-303

  Szabó, Csaba ^a,b  

^a INOTEK CORPORATION   (United States)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Acute; Apoptosis; Blood vessels; Chronic; DNA repair; Drug development; Inflammation; Myocardial infarction; Necrosis; Stroke

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA FRAGMENT; GPI 6150; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INO 1001; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PENTOSYLTRANSFERASE INHIBITOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL PROTECTION; CLINICAL TRIAL; DNA STRAND BREAKAGE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; NONHUMAN; REVIEW; RISK BENEFIT ANALYSIS;

ANIMALS; CARDIOVASCULAR DISEASES; ENZYME INHIBITORS; FORECASTING; HUMANS; NECROSIS; POLY(ADP-RIBOSE) POLYMERASES; THERAPIES, INVESTIGATIONAL;

EID: 21644467334     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570161054368553     Document Type: Review

References (17)

1. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
2. Nicoletti VG, Stella AM. Role of PARP under stress conditions: cell death or protection? Neurochem Res 2003; 28: 187-94.
3. Beneke S, Diefenbach J, Burkle A. Poly(ADP-ribosyl)ation inhibitors: promising drug candidates for a wide variety of pathophysiologic conditions. Int J Cancer 2004; 111: 813-8.
4. Herceg Z, Wang ZQ. Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutat Res 2001; 477: 97-110.
5. Nguewa PA, Fuertes MA, Valladares B, Alonso C, Perez JM. Poly(ADP-Ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications. Prog Biophys Mol Biol 2005; 88: 143-72.
6. Herceg Z, Wang ZQ. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol Cell Biol 1999; 19: 5124-33.
7. Leist M, Single B, Kunstle G, Volbracht C, Hentze H, Nicotera P. Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem Biophys Res Commun 1997; 233: 518-22.
8. Wang ZQ, Stingl L, Morrison C, Jantsch M, Los M, Schulze-Osthoff K, et al. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev 1997; 11: 2347-58.
9. Virag L, Salzman AL, Szabo C. Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 1998; 161: 3753-9.
10. Heller B, Wang ZQ, Wagner EF, Radons J, Burkle A, Fehsel K, et al. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 1995; 270: 11176-80
11. Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998; 95: 3867-72.
12. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997; 3:1089-95.
13. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999; 96: 13978-82.
14. Soriano FG, Pacher P, Mabley J, Liaudet L, Szabo C. Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res 2001; 89: 684-91.
15. Jijon HB, Churchill T, Malfair D, Wessler A, Jewell LD, Parsons HG, et al. Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 2000; 279: G641-51.
16. Kick J, Albicini M, Gröger M, Hauser B, Ehrmann U, Szabó C, et al. Effects of the PARP inhibitor INO-1001 on oxidative DNA damage and repair. Shock 23 (Suppl 2): 58.
17. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Li JH, Zhang J, Smulson ME. Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy. Nucleic Acids Res 2001; 29: 841-9.